448 related articles for article (PubMed ID: 35452854)
21. Spectrum of ANCA-specificities in eosinophilic granulomatosis with polyangiitis. A retrospective multicentre study.
Arnold S; Mahrhold J; Kerstein-Staehle A; Riemekasten G; Csernok E; Hellmich B; Venhoff N; Thiel J; Affeldt K; Jahnke A; Lamprecht P
Clin Exp Rheumatol; 2023 Apr; 41(4):936-942. PubMed ID: 37073637
[TBL] [Abstract][Full Text] [Related]
22. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
Csernok E; Ahlquist D; Ullrich S; Gross WL
Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
[TBL] [Abstract][Full Text] [Related]
23. Laboratory Diagnosis of ANCA-Associated Vasculitis (AAV) Using a Combination of Immunofluorescence Test (IIFT) and Line Immunoassay (LIA): Single-Centre Report From India.
Chauhan R; Jain D; Tiwari AK; Dorwal P; Raina V; Nandi SP
Reumatol Clin (Engl Ed); 2022 Jan; 18(1):15-19. PubMed ID: 35090607
[TBL] [Abstract][Full Text] [Related]
24. Current and emerging techniques for ANCA detection in vasculitis.
Csernok E; Moosig F
Nat Rev Rheumatol; 2014 Aug; 10(8):494-501. PubMed ID: 24890776
[TBL] [Abstract][Full Text] [Related]
25. Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification.
Deshayes S; Martin Silva N; Khoy K; Yameogo S; Mariotte D; Lobbedez T; Aouba A
Rheumatology (Oxford); 2019 Oct; 58(10):1731-1739. PubMed ID: 30805643
[TBL] [Abstract][Full Text] [Related]
26. Childhood-Onset ANCA- Associated Vasculitis: single center experience from Central California.
Singh D; Sukumaran S
Pediatr Rheumatol Online J; 2023 Jul; 21(1):66. PubMed ID: 37400890
[TBL] [Abstract][Full Text] [Related]
27. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
Ozaki S
Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
[TBL] [Abstract][Full Text] [Related]
28. Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.
Kawasaki A; Hasebe N; Hidaka M; Hirano F; Sada KE; Kobayashi S; Yamada H; Furukawa H; Yamagata K; Sumida T; Miyasaka N; Tohma S; Ozaki S; Matsuo S; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N
PLoS One; 2016; 11(5):e0154393. PubMed ID: 27166610
[TBL] [Abstract][Full Text] [Related]
29. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
[TBL] [Abstract][Full Text] [Related]
30. Key advances in the clinical approach to ANCA-associated vasculitis.
Kallenberg CG
Nat Rev Rheumatol; 2014 Aug; 10(8):484-93. PubMed ID: 24980139
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of 12 different assays for detecting ANCA in Chinese patients with GPA and MPA: a multicenter study in China.
Zhang W; Zheng Z; Jia R; Li X; Zuo X; Wu L; Shen N; Li Z; Zhang Y; Wang G; Yu F; Zhang X; Hu S; Zhang M; Li X; Sun S; Xiang Y; Tao Y; Bi L; Li Q; Li Z; Zhu P
Clin Rheumatol; 2019 Dec; 38(12):3477-3483. PubMed ID: 31414304
[TBL] [Abstract][Full Text] [Related]
32. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
[TBL] [Abstract][Full Text] [Related]
33. Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis.
Radice A; Bianchi L; Sinico RA
Autoimmun Rev; 2013 Feb; 12(4):487-95. PubMed ID: 22921790
[TBL] [Abstract][Full Text] [Related]
34. Relapse rate and renal prognosis in ANCA-associated vasculitis according to long-term ANCA patterns.
Oristrell J; Loureiro-Amigo J; Solans R; Valenzuela MP; Monsálvez V; Segarra A; Amengual MJ; Marín A; Feijoo C; Tolosa C
Clin Exp Immunol; 2021 Feb; 203(2):209-218. PubMed ID: 33020895
[TBL] [Abstract][Full Text] [Related]
35. Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays.
Damoiseaux J; Csernok E; Rasmussen N; Moosig F; van Paassen P; Baslund B; Vermeersch P; Blockmans D; Cohen Tervaert JW; Bossuyt X
Ann Rheum Dis; 2017 Apr; 76(4):647-653. PubMed ID: 27481830
[TBL] [Abstract][Full Text] [Related]
36. The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):85-87. PubMed ID: 29185957
[TBL] [Abstract][Full Text] [Related]
37. Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control study.
Culerrier J; Nguyen Y; Karadag O; Yasar Bilge S; Yildrim TD; Ögüt TS; Yazisiz V; Bes C; Celfe A; Yazici A; Sadioglu Cagdas O; Kronbichler A; Jayne D; Gauckler P; Regent A; Teixeira V; Marchand-Adam S; Duffau P; Housz-Oro SI; Droumaguet C; Andre B; Luca L; Lechtman S; Aouba A; Lebas C; Servettaz A; Dernoncourt A; Ruivard M; Milesi AM; Poindron V; Jego P; Padoan R; Delvino P; Vandergheynst F; Pagnoux C; Yacyshyn E; Lamprecht P; Flossmann O; Puéchal X; Terrier B
Rheumatology (Oxford); 2024 Apr; 63(4):999-1006. PubMed ID: 37354498
[TBL] [Abstract][Full Text] [Related]
38. A multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies.
Bossuyt X; Rasmussen N; van Paassen P; Hellmich B; Baslund B; Vermeersch P; Blockmans D; Cohen Tervaert JW; Csernok E; Damoiseaux J
Rheumatology (Oxford); 2017 Sep; 56(9):1533-1541. PubMed ID: 28541581
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of PR3- and MPO-ANCA line and dot immunoassays in ANCA-associated vasculitis.
Kempiners N; Mahrhold J; Hellmich B; Csernok E
Rheumatology (Oxford); 2021 Sep; 60(9):4390-4394. PubMed ID: 33316047
[TBL] [Abstract][Full Text] [Related]
40. ANCA detection with solid phase chemiluminescence assay: diagnostic and severity association in vasculitis.
Renuncio-García M; Calvo-Río V; Benavides-Villanueva F; Al Fazazi S; Rodríguez-Vidriales M; Escagedo-Cagigas C; Martín-Penagos L; Irure-Ventura J; López-Hoyos M; Blanco R
Immunol Res; 2024 Feb; 72(1):128-133. PubMed ID: 37676628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
